estramustine-binding protein

07/01/2007 - "Mice with DU-145 prostate cancer xenografts received 243 microCi of I-125-labeled EMBP-AB (RI-EMBP-AB). "
07/01/2007 - "Distribution of radioiodinated estramustine binding protein antibody in mice with DU-145 prostate cancer xenograft."
09/01/1994 - "According to these results, EMBP was expressed mainly in the diseased peripheral zone (PZ), where PIN and prostatic cancer have their highest prevalence."
11/01/1988 - "Our findings suggest a mechanism for selective uptake of these metabolites in prostatic cancer (estramustine-binding protein). "
01/01/1988 - "EMBP may therefore be a marker of therapeutic response in human prostatic cancer. "

09/01/1998 - "Thus, this supports the hypothesis that the EMBP is responsible for the retention of EoM and EaM in the prostate tumor."
09/01/1998 - "These data demonstrate that 12 h after a single i.v. dose of 600 mg of EMP the levels of the cytotoxic metabolites EoM and EaM are substantially higher in the tumor than in the serum of the same patient and that a correlation exists between the levels of EaM in the tumor and the levels of EMBP. "
09/01/1998 - "A significant correlation was found between the levels of EaM (r = 0.60) and the levels of EMBP in the tumor. "
09/01/1998 - "The levels of EMBP were higher in T3 tumors than in T2 tumors, 54.1 and 40.7 ng/g tissue, respectively. "
04/01/1998 - "Results from in vitro experiments suggest that because of their high nonspecific binding, the compounds are unsuitable for positron emission tomography as imaging agents for the estramustine binding protein in cancer."

07/01/2013 - "Nasal polyps correlated with higher expression of CD27 and EMBP, but in CRS patients without polyps CD27 and EMBP was also significantly greater in biofilm-positive specimens compared with biofilm-negative specimens. "

07/01/2013 - "Nasal polyps correlated with higher expression of CD27 and EMBP, but in CRS patients without polyps CD27 and EMBP was also significantly greater in biofilm-positive specimens compared with biofilm-negative specimens. "

08/01/1995 - "In this study the expression of EMBP was evaluated by immunohistochemistry and radioimmunoassay in a series of astrocytoma of different grades. "
08/01/1995 - "Prognostic implication of estramustine-binding protein in astrocytoma."
09/15/1994 - "Immunohistochemistry revealed a pronounced reactivity for EMBP in astrocytoma grades III-IV as well as in metastatic prostatic adenocarcinoma used as positive control. "
09/15/1994 - "In this study, we have analysed the expression of an EMBP-like protein in astrocytoma specimens. "
08/01/1995 - "It is proposed that EMBP might have a value to predict survival in patients with astrocytoma, especially if estramustine is to be included in the treatment schedule. "